0001802768-24-000040.txt : 20240628
0001802768-24-000040.hdr.sgml : 20240628
20240628170950
ACCESSION NUMBER: 0001802768-24-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240628
DATE AS OF CHANGE: 20240628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bassler Bonnie L
CENTRAL INDEX KEY: 0001683607
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 241086799
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
wk-form4_1719608984.xml
FORM 4
X0508
4
2024-06-28
0
0001802768
Royalty Pharma plc
RPRX
0001683607
Bassler Bonnie L
C/O ROYALTY PHARMA PLC
110 E. 59TH STREET
NEW YORK
NY
10022
1
0
0
0
0
Class A Ordinary Shares
2024-06-28
4
A
0
1399
26.7998
A
58454
D
Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.
/s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler
2024-06-28